Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Furosemide measurement |
Component |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide poisoning |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Accidental frusemide poisoning |
Causative agent |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Intentional furosemide poisoning |
Causative agent |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
forgiftning med furosemid, uvist med hvilken hensigt |
Causative agent |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Frusemide adverse reaction (disorder) |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Allergy to furosemide |
Causative agent |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Frusemide overdose (disorder) |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Accidental frusemide overdose |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Intentional frusemide overdose |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
overdosis af furosemid, uvist med hvilken hensigt |
Causative agent |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 20 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 40 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 50 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 10 mg/ml injektionsvæske, opløsing, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Furosemide 1 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
furosemid 10 mg/ml injektionsvæske, opløsing, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 10 mg/ml injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing furosemide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing furosemide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 10mg/mL injection solution 2ml ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Furosemide 40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Furosemide 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 40 mg + kalium 8 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
frusemid 20 mg + kalium 10 mmol tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
kombinationspræparat, amiloridhydrochlorid + furosemid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Co-amilofruse tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing furosemide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing furosemide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing furosemide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
frusemid 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
furosemid 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
furosemid 10 mg/ml injektionsvæske, opløsing, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Accidental frusemide poisoning |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Intentional furosemide poisoning |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing furosemide and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Allergy to furosemide |
Causative agent |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Furosemide 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Frusemide+potassium 40mg/8Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Frusemide+potassium 20mg/10Mmol prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Amiloride hydrochloride 10 mg and furosemide 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Furosemide 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride- and furosemide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Furosemide 20 mg and spironolactone 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing furosemide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 4 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 4 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 1 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Furosemide 1 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 20 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 20 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 50 milligram/5 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 50 milligram/5 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 80 milligram/8 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely furosemide 80 milligram/8 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Furosemide (substance) |
Inferred relationship |
Some |
1 |
Product containing furosemide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
2 |
Product containing only amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Furosemide (substance) |
Inferred relationship |
Some |
1 |